Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

The Phase Ⅱ/Ⅲ Trial of LYB001

  • Read more about The Phase Ⅱ/Ⅲ Trial of LYB001

Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

  • Read more about Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection

  • Read more about Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection

Telemonitoraggio Domiciliare Della Saturazione Arteriosa di Ossigeno in Pazienti COVID-19

  • Read more about Telemonitoraggio Domiciliare Della Saturazione Arteriosa di Ossigeno in Pazienti COVID-19

StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.

  • Read more about StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.

α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

  • Read more about α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

Trial of 2nd Booster Dose of COVID-19 Vaccine

  • Read more about Trial of 2nd Booster Dose of COVID-19 Vaccine

Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

  • Read more about Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

  • Read more about PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Beta-glucans for Hospitalised Patients With COVID-19

  • Read more about Beta-glucans for Hospitalised Patients With COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • Current page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA